Results 61 to 70 of about 26,238 (200)
Production of the PET radionuclide 61Cu via the 62Ni(p,2n)61Cu nuclear reaction
EJNMMI Radiopharmacy and ChemistryBackground There are only a handful of true theranostic matched pairs, and in particular the theranostic radiocopper trio 61Cu, 64Cu and 67Cu, for diagnosis and therapy respectively, is a very attractive candidate. In fact, the alternative of two imaging
Santiago Andrés Brühlmann +3 more
doaj +1 more source
Technology Transfer of O-(2-[18F] Fluoroethyl)-L-Tyrosine (IASOglio®) Radiopharmaceutical
Background/Objectives: Gliomas, including the most aggressive subtype—glioblastoma multiforme, are brain tumors with an unfavorable prognosis and high mortality. Early diagnosis is essential to improve treatment efficacy.
Alessia Danti +9 more
core +1 more source
Synthesis and preclinical evaluation of FAP-targeting radiotracers for PET and optical imaging
EJNMMI Radiopharmacy and ChemistryBackground Successful treatment of solid cancers relies on precise diagnosis, e.g. using noninvasive molecular imaging, followed by surgical removal and/or chemo/immunotherapy.
Jürgen Kogler +4 more
doaj +1 more source
CellsPancreatic ductal adenocarcinoma (PDAC) is a highly heterogeneous cancer with a severe stromal reaction mediated by pancreatic stellate cells (PSCs), leading to increased resistance to chemotherapy and radiotherapy.
Alina Doctor +3 more
doaj +1 more source
Cardiovascular disease and radiopharmaceutical therapies:an underestimated risk? [PDF]
In conclusion, although a clear relationship between radiation exposure from radiopharmaceutical therapy and CVD has not yet been established with scientific certainty, there is sufficient evidence in the literature to suggest that such a relationship ...
Lassmann, Michael +2 more
core +1 more source
Radiopharmaceutical pharmacokinetics in animals: critical considerations [PDF]
, 2009 Since the advent of single photon emission computerized tomography (SPECT) and positron emission tomography (PET) various chemical ligands have been labeled with radionuclides and evaluated as tracer compounds in animal models to ascertain their ...
GIRON, MARIA CECILIA
core
Designing assessment for radiopharmaceutical scientist training
, 2017 ACER is working with radiopharmaceutical scientists to develop fit-for-purpose progressive assessment practices for a new training program, as Jacob Pearce ...
Pearce, Jacob
core +2 more sources
Annual Report 2003 - Institute of Bioinorganic and Radiopharmaceutical chemistry [PDF]
, 2004 The report gives an overview on the activities of the Institute ofBioinorganic and Radiopharmaceutical Chemistry in ...
Spies, H., Seifert, S.
core +3 more sources
Molecules, 2018 Sigma-1 receptors (Sig1R) are highly expressed in various human cancer cells and hence imaging of this target with positron emission tomography (PET) can contribute to a better understanding of tumor pathophysiology and support the development of ...
Mathias Kranz +12 more
doaj +1 more source
Translational approach to radiopharmaceutical development
, 2019 International audienceNuclear medicine, which encompasses the medical field of molecular imaging and radionuclide therapy, brings together many disciplines, and radiopharmacy requires that pharmacy, physics and medicine work together within a synergetic ...
Fragoso Costa, Pedro, Rbah-Vidal, Latifa
core +3 more sources